According to Adverum Biotechnologies 's latest financial reports and stock price the company's current Operating Margin is -1,940.53%. At the end of 2021 the company had an Operating Margin of -1,940.53%.
Year | Operating Margin | Change |
---|---|---|
2021 | -1,940.53% | |
2019 | -25,794.40% | 462.84% |
2018 | -4,582.94% | 50.92% |
2017 | -3,036.61% | -61.42% |
2016 | -7,870.93% | 284.65% |
2015 | -2,046.27% | -53.93% |
2014 | -4,441.26% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 0.00% | N/A | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.